281 related articles for article (PubMed ID: 1893617)
1. IgG human monoclonal anti-DNA autoantibodies from patients with systemic lupus erythematosus.
Winkler TH; Jahn S; Kalden JR
Clin Exp Immunol; 1991 Sep; 85(3):379-85. PubMed ID: 1893617
[TBL] [Abstract][Full Text] [Related]
2. Production and analysis of IgG monoclonal anti-DNA antibodies from systemic lupus erythematosus (SLE) patients.
Ehrenstein M; Longhurst C; Isenberg DA
Clin Exp Immunol; 1993 Apr; 92(1):39-45. PubMed ID: 8385586
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring V region connected antibodies inhibit anti-dsDNA antibody reactivity with dsDNA.
Srdic-Rajic T; Jurisic V; Andrejevic S; Bonaci-Nikolic B; Bowker T; Concas D; Metlas R
Immunobiology; 2012 Jan; 217(1):111-7. PubMed ID: 21840618
[TBL] [Abstract][Full Text] [Related]
4. Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?
Mason LJ; Ravirajan CT; Rahman A; Putterman C; Isenberg DA
Arthritis Rheum; 2004 Mar; 50(3):866-70. PubMed ID: 15022329
[TBL] [Abstract][Full Text] [Related]
5. A comparison of three methods for production of human hybridomas secreting autoantibodies.
Niedbala WG; Stott DI
Hybridoma; 1998 Jun; 17(3):299-304. PubMed ID: 9708833
[TBL] [Abstract][Full Text] [Related]
6. A bispecific dsDNAxmonoclonal antibody construct for clearance of anti-dsDNA IgG in systemic lupus erythematosus.
Lindorfer MA; Schuman TA; Craig ML; Martin EN; Taylor RP
J Immunol Methods; 2001 Feb; 248(1-2):125-38. PubMed ID: 11223074
[TBL] [Abstract][Full Text] [Related]
7. Studies of human polyclonal and monoclonal antibodies binding to lupus autoantigens and cross-reactive antigens.
Sharma A; Isenberg D; Diamond B
Rheumatology (Oxford); 2003 Mar; 42(3):453-63. PubMed ID: 12626796
[TBL] [Abstract][Full Text] [Related]
8. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
Rauch J; Massicotte H; Tannenbaum H
J Immunol; 1985 Oct; 135(4):2385-92. PubMed ID: 3875652
[TBL] [Abstract][Full Text] [Related]
9. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A
Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of human monoclonal anti-idiotype antibodies to anti-dsDNA antibodies.
Zhang W; Frank MB; Reichlin M
Lupus; 2002; 11(6):362-9. PubMed ID: 12139374
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells.
Zhang J; Jacobi AM; Wang T; Diamond B
Mol Med; 2008; 14(11-12):675-81. PubMed ID: 18677426
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous antibody-secreting cells against DNA and common environmental antigens in systemic lupus erythematosus.
Dar O; Salaman MR; Seifert MH; Isenberg DA
J Autoimmun; 1990 Oct; 3(5):523-30. PubMed ID: 2252522
[TBL] [Abstract][Full Text] [Related]
14. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
Sjoholm AG; Martensson U; Sturfelt G
J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
17. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
Guo H; Leung JC; Chan LY; Chan TM; Lai KN
Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
[TBL] [Abstract][Full Text] [Related]
18. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity.
Hanaoka H; Okazaki Y; Satoh T; Kaneko Y; Yasuoka H; Seta N; Kuwana M
Lupus; 2012 Oct; 21(12):1284-93. PubMed ID: 22740429
[TBL] [Abstract][Full Text] [Related]
19. Anti-apolipoprotein A-I autoantibody: characterization of monoclonal autoantibodies from patients with systemic lupus erythematosus.
Abe H; Tsuboi N; Suzuki S; Sakuraba H; Takanashi H; Tahara K; Tonozuka N; Hayashi T; Umeda M
J Rheumatol; 2001 May; 28(5):990-5. PubMed ID: 11361227
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity of IgG anti-DNA-secreting B cells in patients with systemic lupus erythematosus.
Klinman DM; Shirai A; Conover J; Steinberg AD
Eur J Immunol; 1994 Jan; 24(1):53-8. PubMed ID: 8020571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
